Matches in Wikidata for { <http://www.wikidata.org/entity/Q85300328> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q85300328 description "artículu científicu espublizáu n'ochobre de 2012" @default.
- Q85300328 description "scientific article published on 26 October 2012" @default.
- Q85300328 description "wetenschappelijk artikel" @default.
- Q85300328 description "наукова стаття, опублікована в жовтні 2012" @default.
- Q85300328 name "Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series" @default.
- Q85300328 name "Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series" @default.
- Q85300328 type Item @default.
- Q85300328 label "Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series" @default.
- Q85300328 label "Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series" @default.
- Q85300328 prefLabel "Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series" @default.
- Q85300328 prefLabel "Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series" @default.
- Q85300328 P1433 Q85300328-981B3008-5DC6-4931-A15A-E59F262A76AC @default.
- Q85300328 P1476 Q85300328-210E5ABB-749B-4A76-8E8E-830DE0FE5FFF @default.
- Q85300328 P2093 Q85300328-55742769-8DEF-486C-88EE-998ABD4CD7EE @default.
- Q85300328 P2093 Q85300328-65C045E6-5552-4339-988B-C2453E2B3767 @default.
- Q85300328 P2093 Q85300328-6B9F7E49-84FD-4C79-BE90-9E5A203552F0 @default.
- Q85300328 P2093 Q85300328-839AF3DF-E4BD-40F0-9ABC-A2F7BC2C30BE @default.
- Q85300328 P2093 Q85300328-8D054FE2-056A-4AA2-9711-7F3E4F213B64 @default.
- Q85300328 P2093 Q85300328-916344AE-DBB3-4404-B99B-A107ABB60B68 @default.
- Q85300328 P2093 Q85300328-C74AA069-591F-4EBB-8698-2BBB13A9DE58 @default.
- Q85300328 P2093 Q85300328-DDAC133D-EB1A-409B-B4F2-537C67ACC505 @default.
- Q85300328 P304 Q85300328-DAA1EB6E-7CD9-4BD3-97DF-E600F9B427C9 @default.
- Q85300328 P31 Q85300328-652AFC99-C1FE-4C86-93D3-A5A553468727 @default.
- Q85300328 P356 Q85300328-7E05A0BA-E7BE-4077-BE2A-D62DE2F8D51E @default.
- Q85300328 P433 Q85300328-2AEC6D70-2648-4FF3-909A-DA08C2D0D1AA @default.
- Q85300328 P478 Q85300328-92A57096-76C0-4A69-A34B-A3D31A744EF9 @default.
- Q85300328 P50 Q85300328-69B4EE9F-13C6-486B-824B-4455161F7F42 @default.
- Q85300328 P50 Q85300328-A5B48F50-AE74-4EDC-AE9F-37BFFBBE7AE1 @default.
- Q85300328 P577 Q85300328-6EE0DEFD-EC9D-4B35-A5E9-F6CC0B955C0D @default.
- Q85300328 P698 Q85300328-947C5238-19AA-4405-ABBD-707D0B06AE2B @default.
- Q85300328 P356 MDS536 @default.
- Q85300328 P698 23104720 @default.
- Q85300328 P1433 Q326122 @default.
- Q85300328 P1476 "Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series" @default.
- Q85300328 P2093 "A Vincent-Salomon" @default.
- Q85300328 P2093 "F Picaud" @default.
- Q85300328 P2093 "J Peron" @default.
- Q85300328 P2093 "J Wassermann" @default.
- Q85300328 P2093 "L Albiges" @default.
- Q85300328 P2093 "M Debled" @default.
- Q85300328 P2093 "M J Rodrigues" @default.
- Q85300328 P2093 "P H Cottu" @default.
- Q85300328 P304 "916-924" @default.
- Q85300328 P31 Q13442814 @default.
- Q85300328 P356 "10.1093/ANNONC/MDS536" @default.
- Q85300328 P433 "4" @default.
- Q85300328 P478 "24" @default.
- Q85300328 P50 Q58259189 @default.
- Q85300328 P50 Q84987221 @default.
- Q85300328 P577 "2012-10-26T00:00:00Z" @default.
- Q85300328 P698 "23104720" @default.